United States · FDA National Drug Code directory
Cetirizine Hydrochloride (Allergy)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58602-806_a74bd49f-8718-4483-9019-b761138669c9
- Product NDC
- 58602-806
- Form
- CAPSULE
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- Aurohealth LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180720
- Source listing expiry
- 20271231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (58602-806-04) / 12 CAPSULE in 1 BOTTLE · 58602-806-04
- 1 BOTTLE in 1 CARTON (58602-806-12) / 40 CAPSULE in 1 BOTTLE · 58602-806-12
- 65 BOTTLE in 1 CARTON (58602-806-16) / 65 CAPSULE in 1 BOTTLE · 58602-806-16
- 1 BOTTLE in 1 CARTON (58602-806-53) / 25 CAPSULE in 1 BOTTLE · 58602-806-53
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →